There are plenty of ways for a more optimistic forecast to reach $80 or $100. Azetukalner could exceed $3 billion in epilepsy ...

KETAFREE can turn NRx Pharmaceuticals’ ketamine opportunity into a commercial business, provided FDA approval leads to a ...

Study of more than 171,000 adults followed for over a decade found a dose-dependent association between several food ...

Tearing up at commercials more with age isn't weakness. Research shows older adults feel mixed emotions more often and stop ...

Let's take a beat and talk about the hottest new health trend.

While regional envoys and Iranian representatives prepared for Monday discussions in Oman to restore routine oil transport ...

Axsome is already selling drugs with 65% revenue growth, while Viking bets on obesity treatments still in trials, a classic ...

If you’re looking to dig deeper into Broadway gossip, why not check some federal financial databases? Producers usually like to keep their ...

Toad smoking has been called "the Everest of psychedelics." Over the past decade, this practice has "gone exponential," a clinical psychologist who studies psychedelics tells journalist Kimon de ...

One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive ...

Mr. Englese’s leadership of Tonix’s commercial organization since 2024 has included the go-to-market strategy and U.S. launch of TONMYA®, with growth across sales, managed care, and patient access ...

Financial distress correlates with two-and-a-half times higher rates of depression, anxiety and sleep issues. Chennells ...